12 Best Diagnostics Stocks to Invest In Right Now
According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.
Thermo Fisher Scientific Inc. (TMO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 2,665,902 | $1,386,882,965 | +2% | 0.55% |
| 2. | Unisphere Establishment Hani Lazkani (Ceo) | 1,700,000 | $884,391,000 | 7.7% | |
| 3. | Generation Investment Management David Blood And Al Gore | 1,571,734 | $817,663,180 | -1% | 4.26% |
| 4. | Farallon Capital Thomas Steyer | 1,233,256 | $641,576,769 | +74% | 3.25% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 933,200 | $485,478,636 | +82% | 1.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $535.93 | 4 | Director | 14,268 | 2024-12-09 | Filing | |
| $555.89 | 16 | Director | 14,264 | 2024-11-07 | Filing | |
| $526.15 | 4 | Officer | 13,101 | 2023-06-26 | Filing | |
| $134.16 | 1,000 | Director | 14,636 | 2015-12-11 | Filing | |
| $45.84 | 36 | Director | 25,914 | 2010-08-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $532.53 | 3,775 | Officer | 10,816 | 2025-03-10 | Filing | |
| $524.22 | 1,245 | Officer, Director | 115,174 | 2025-03-05 | Filing | |
| $523.29 | 1,554 | Officer, Director | 116,419 | 2025-03-05 | Filing | |
| $521.24 | 200 | Officer, Director | 117,973 | 2025-03-05 | Filing | |
| $519.61 | 851 | Officer, Director | 118,173 | 2025-03-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 82,953 | $41,277,690 | 0.59% | |
| 2. | 51,760 | $25,755,776 | 0.74% | |
| 3. | 45,636 | $22,708,474 | 4.69% | |
| 4. | 18,489 | $9,200,126 | 1.01% | |
| 5. | 11,649 | $5,796,542 | 0.4% |
News See All
13 Best Healthcare Dividend Stocks to Invest in
The US healthcare sector has been at the forefront since the emergence of COVID-19 in 2020, leading to a significant transformation in the industry.
Thermo Fisher Scientific (TMO) Fell as Expectations for Demand Recovery in 2025 Continue to Moderate
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Strong Buy Stocks To Buy Right Now
Fears of a slowing economy have hit stocks recently, along with concerns that Trump's tariffs will raise prices for consumers and lead to more inflation.
10 Best Diabetes Stocks To Buy According to Billionaires
The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income countries.
Here's Why Thermo Fisher Scientific (TMO) Fell in Q4
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The U.S.
Thermo Fisher Scientific Inc. (TMO): A Bull Case Theory
We came across a bullish thesis on Thermo Fisher Scientific Inc. (TMO) on Substack by FluentInQuality. In this article, we will summarize the bulls’ thesis on TMO. Thermo Fisher Scientific Inc.
10 Best Affordable Dividend Stocks to Buy According to Hedge Funds
In 2024, several major tech companies surprised investors by announcing their first-ever dividend payments.
12 High Growth Low Dividend Stocks To Invest In
Dividend stocks offer investors a reliable stream of income, no matter how the market is doing.
12 Best Scientific Instruments Stocks to Buy Right Now
The global scientific instruments market has been experiencing steady growth and is expected to continue its upward trajectory in the coming years.
Billionaire Hedge Funds
